Fulvestrant Medical Valley

Fulvestrant is a medication used for specific hormonal conditions. This intramuscular injection is manufactured by Medical Valley Invest Ab and is available in the EU market.

Fulvestrant is primarily used in the management of hormone receptor-positive breast cancer. It works by targeting estrogen receptors, which can help in controlling the growth of certain types of cancer cells. This medication is often considered when other treatments have not been effective or are no longer suitable.

Common effects of Fulvestrant may include injection site reactions, such as pain, swelling, or redness. Some individuals might experience fatigue, nausea, or headaches. These effects vary among users and are not experienced by everyone.

Fulvestrant should be administered by healthcare professionals to ensure proper intramuscular injection. It is important to discuss any existing medical conditions or allergies with your healthcare provider before starting this treatment. Regular monitoring may be required during the course of treatment.

Fulvestrant may interact with other medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with your healthcare provider as it may affect the treatment.